Cord blood plasma eyed as treatment for dry AMD
NCT ID NCT05706896
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 35 times
Summary
This study tests if injections of a substance made from umbilical cord blood (called platelet-rich plasma) can slow the worsening of dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. About 36 people aged 65 and older with dry AMD in both eyes will receive either the treatment or a sham injection. The goal is to see if the treatment can stop or slow the growth of damaged areas in the eye and possibly improve vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
RECRUITINGRome, 00168, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.